ClinicalTrials.Veeva

Menu

EMPOWER - BAME vs COVID

F

Future Genetics

Status

Withdrawn

Conditions

Health Disparities
COVID-19, SARS-CoV 2 Infection

Study type

Observational

Funder types

Other

Identifiers

NCT04399733
EMPOWER-BAME vs COVID

Details and patient eligibility

About

The COVID-19 virus pandemic has massively affected us all. Moreover, there is a disproportionately high number of COVID-19 severe infections and deaths in British Black, Asian and minority ethnic (BAME) patients. This clinical study plans to discover new ways of protecting people from this virus by looking at our DNA and biology.

Full description

The COVID-19 virus pandemic has massively affected us all. We now know there is a much larger proportion of British Black, Asian and minority ethnic (BAME) patients suffering from COVID-19 infections. This disproportionate level of infection and severity of disease has raised concerns and worries. Other research from April 2020 showed that 71% of the nurses and midwives and 94% of the doctors and dentists that died of COVID-19 infections were from a BAME background despite this group representing 20% and 44% of the workforce respectively. The survival picture is also grim for Black and Asian members of the public where we see disproportionately high rates of deaths. Research estimates that our DNA and the environment equally influence the risk for infection. This clinical study plans to better understand our DNA. Some of the things we will be looking at is age, sex, ethnicity and any illnesses such as diabetes or blood pressure. We will ask people for some spit and look at their medical records. This may help us find some of the reasons why this virus has different effects on people and how we might protect people from COVID-19.

Sex

All

Ages

6+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. All competent adult and children above the age of 5 years

  2. Subjects agree to:

    1. Gift saliva (spit) samples
    2. Provide Consent for access to medical and health records

Exclusion criteria

  1. Patient is not registered with the NHS for care.
  2. Adults lacking capacity
  3. Children under the age of 6 years.

Trial design

0 participants in 1 patient group

Ethnicity
Description:
Patients will be segmented on a 1:1:1 ratio similar to the EMPOWER-1 study based on ethnicity (White, Black, South Asian).

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems